Spots Global Cancer Trial Database for digoxin
Every month we try and update this database with for digoxin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis | NCT05741372 | Liver Cirrhosis | Rosuvastatin Digoxin Metformin hydro... Furosemide | 18 Years - 75 Years | Boehringer Ingelheim | |
| Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer | NCT00281021 | Carcinoma, Non-... | Erlotinib plus ... | 18 Years - | University of Louisville | |
| A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma | NCT01765569 | Malignant Melan... | Digoxin Vemurafenib | 18 Years - | Hoffmann-La Roche | |
| Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects | NCT01517399 | Solid Tumors | tivantinib omeprazole s-warfarin caffeine vitamin K digoxin midazolam | 18 Years - | Daiichi Sankyo | |
| Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma | NCT05507775 | Non-Medullary T... | Digoxin tablet | 18 Years - | Radboud University Medical Center | |
| Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects | NCT06348290 | Solid Tumor, Ad... | JMKX001899 Itraconazole Midazolam Rifampin dextromethorpha... Rosuvastatin digoxin | 18 Years - 45 Years | Jemincare | |
| A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer | NCT04094519 | Prostate Cancer | enzalutamide enzalutamide Pl... digoxin rosuvastatin | 18 Years - | Astellas Pharma Inc | |
| A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. | NCT02333643 | Cutaneous Warts | CLS003 Furosemide Digoxin Vehicle topical | 18 Years - 65 Years | Maruho Co., Ltd. | |
| Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors. | NCT02106845 | Neoplasms | Digoxin Rosuvastatin Regorafenib (St... | 18 Years - | Bayer | |
| Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects | NCT06348290 | Solid Tumor, Ad... | JMKX001899 Itraconazole Midazolam Rifampin dextromethorpha... Rosuvastatin digoxin | 18 Years - 45 Years | Jemincare | |
| Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma | NCT02212639 | Kaposi' s Sarco... Classic Kaposi'... Endemic Kaposi'... Lymph Angio Pro... | digoxin | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. | NCT02333643 | Cutaneous Warts | CLS003 Furosemide Digoxin Vehicle topical | 18 Years - 65 Years | Maruho Co., Ltd. | |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | NCT06030622 | Pancreatic Canc... | Gemcitabine and... C3 (Metformin, ... | 18 Years - | State University of New York - Downstate Medical Center | |
| A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer | NCT04094519 | Prostate Cancer | enzalutamide enzalutamide Pl... digoxin rosuvastatin | 18 Years - | Astellas Pharma Inc | |
| DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer | NCT01763931 | Breast Cancer | Digoxin | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma | NCT02212639 | Kaposi' s Sarco... Classic Kaposi'... Endemic Kaposi'... Lymph Angio Pro... | digoxin | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer | NCT00650910 | Neoplasms, Brea... | lapatinib Digoxin | 18 Years - 65 Years | GlaxoSmithKline | |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | NCT06030622 | Pancreatic Canc... | Gemcitabine and... C3 (Metformin, ... | 18 Years - | State University of New York - Downstate Medical Center | |
| PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates | NCT04887194 | Advanced Solid ... | Sitravatinib Warfarin Dextromethorpha... Midazolam Digoxin Rosuvastatin Nivolumab | 18 Years - | Mirati Therapeutics Inc. | |
| A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis | NCT05741372 | Liver Cirrhosis | Rosuvastatin Digoxin Metformin hydro... Furosemide | 18 Years - 75 Years | Boehringer Ingelheim | |
| Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma | NCT05507775 | Non-Medullary T... | Digoxin tablet | 18 Years - | Radboud University Medical Center | |
| A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors | NCT05828303 | Advanced Solid ... Metastatic Soli... | TPX-0005 Metformin Hydro... Digoxin Rosuvastatin Ca... | 18 Years - | Turning Point Therapeutics, Inc. | |
| Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | NCT02740712 | Neoplasms | Caffeine Warfarin Omeprazole Midazolam digoxin Vitamin K Rucaparib | 18 Years - | pharmaand GmbH | |
| A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors | NCT02626234 | cMET-dysregulat... | INC280 digoxin rosuvastatin | 18 Years - | Novartis | |
| Capecitabine With Digoxin for Metastatic Breast Cancer | NCT01887288 | Metastatic Brea... | Capecitabine Digoxin | 18 Years - | Western Regional Medical Center | |
| Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients | NCT02906800 | Head and Neck C... | Digoxin | 19 Years - 69 Years | Assistance Publique - Hôpitaux de Paris | |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | NCT06030622 | Pancreatic Canc... | Gemcitabine and... C3 (Metformin, ... | 18 Years - | State University of New York - Downstate Medical Center | |
| A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors | NCT05828303 | Advanced Solid ... Metastatic Soli... | TPX-0005 Metformin Hydro... Digoxin Rosuvastatin Ca... | 18 Years - | Turning Point Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
